Board Changes
Updated : 07:01
ELIXIRR INTERNATIONAL PLC
("Elixirr", the "Company" or "Group")
Board Changes
Elixirr International plc (AIM:ELIX), an established, global, award-winning, challenger consultancy, announces the following changes to its Board of Directors.
Graham Busby, Co-Founder & Chief Financial Officer, will be appointed as Deputy Chief Executive Officer of Elixirr with effect from 1 January 2025. In this role, Graham will continue to be responsible for the Group's acquisition strategy which he has led since 2020. Nick Willott, Finance Director and Company Secretary, will be appointed as Chief Financial Officer with effect from 1 January 2025 and is expected to join the Board of Elixirr following completion of requisite due diligence procedures. Stephen Newton will continue as Chief Executive Officer.
The Company also announces that Ian Ferguson, Co-Founder & Director, will step down from the Board on 1 January 2025, becoming a Board Advisor.
A further announcement will be made in due course regarding Nick's formal appointment to the board, containing requisite disclosures in accordance with Schedule Two, paragraph (g) of the AIM Rules for Companies.
Commenting on the board changes, Founder & CEO of Elixirr, Stephen Newton said:
"We are delighted to announce the appointments of Graham and Nick as Deputy CEO and CFO respectively. Their deep understanding of the business, together with their technical knowledge and market expertise will further strengthen the Board and support the Company as it continues its strong trajectory of growth. Graham has operated as de facto Deputy Chief Executive Officer for several years working side-by-side with me every day, and Nick has performed exceptionally as our Finance Director and Company Secretary since joining us in 2020. We will continue to work together as a team in the years going forward as we continue to disrupt the consulting market.
The Board, and I personally, wish to thank Ian for his significant contributions as a Board Director and we look forward to his continued counsel as an ongoing advisor to the Board as well as receive his guidance and wisdom on special projects, particularly around M&A."
Enquiries:
For enquiries, please refer to our Investor Contacts page:
https://www.elixirr.com/investors/investor-contacts
Elixirr International plc +44 (0)20 7220 5410
Stephen Newton, Chief Executive Officer
Graham Busby, Chief Financial Officer
investor-relations@elixirr.com
Cavendish Capital Markets Ltd (Nominated Adviser & Broker) +44 (0)20 7220 0500
Stephen Keys, Callum Davidson (Corporate Finance),
Sunila De Silva (ECM)
About Elixirr International plc
Elixirr is an award-winning global consulting firm working with clients across a diverse range of industries, markets and geographies.
Founded in 2009, the firm set out to be the 'challenger consultancy' and do things differently than the large corporate consultancies dominating the industry: working openly and collaboratively with clients from start to finish, delivering outcomes based on innovative thinking, not methodology, and treating each client's business like their own. Elixirr has been quoted on the AIM market of the London Stock Exchange since 2020. In addition to strong organic growth, Elixirr has acquired seven boutique firms - Den Creative, Coast Digital, The Retearn Group, iOLAP, Responsum, Insigniam and Hypothesis - to grow the Group's capabilities, diversify the business, expand into new geographies and access new clients.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.